Ticagrelor Versus Clopidogrel in Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention for Acute Coronary Syndrome in Chronic Kidney Disease

Tan MC 1 , Vignarajah A 2 , Winson T 3 , Yeo YH 4 , Ang QX 5 , Ibrahim R 6 Show all authors , Lee JZ 7

Affiliations 

  • 1 Department of Medicine, Newark, New Jersey; Department of Cardiovascular Medicine, Mayo Clinic Arizona, Phoenix, Arizona
  • 2 Department of Medicine, Cleveland Clinic Fairview Hospital, Cleveland, Ohio
  • 3 Department of Medicine, AIMST University, Bedong, Malaysia
  • 4 Department of Internal Medicine/Pediatrics, Beaumont Health, Royal Oak, Michigan
  • 5 Department of Medicine, Michigan State University/Sparrow Hospital, Lansing, Michigan
  • 6 Department of Cardiovascular Medicine, Mayo Clinic Arizona, Phoenix, Arizona
  • 7 Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. Electronic address: LEEJ67@ccf.org
Am J Cardiol, 2025 Feb 20;244:1-2.
PMID: 39984152 DOI: 10.1016/j.amjcard.2025.02.016

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications